We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$2.08B
AUM Growth
+$162M
Cap. Flow
+$113M
Cap. Flow %
5.42%
Top 10 Hldgs %
60.28%
Holding
408
New
78
Increased
225
Reduced
57
Closed
9

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$30.9M
2
PFE icon
Pfizer
PFE
+$4.57M
3
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$4.1M
4
XOM icon
ExxonMobil
XOM
+$3.59M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$2.76M

Top Sells

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$3.46M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$1.29M
3
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.06M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$871K
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$864K

Sector Composition

Rank Sector Weight
1 Technology 2.4%
2 Industrials 2.28%
3 Financials 2.13%
4 Energy 1.92%
5 Healthcare 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSM icon
226
TSMC
TSM
$2.09T
$453K 0.02%
11,568
+1,510
+15% +$62.2K
TGT icon
227
Target
TGT
$65.6B
$451K 0.02%
5,213
+486
+10% +$39.3K
CAT icon
228
Caterpillar
CAT
$373B
$449K 0.02%
3,299
+564
+21% +$74.5K
TGE
229
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$446K 0.02%
21,120
– –
EMR icon
230
Emerson Electric
EMR
$83.3B
$443K 0.02%
6,652
+2,602
+64% +$174K
ARNA
231
DELISTED
Arena Pharmaceuticals Inc
ARNA
$440K 0.02%
7,500
– –
ENZL icon
232
iShares MSCI New Zealand ETF
ENZL
$78M
$432K 0.02%
8,100
– –
NVO
233
Novo Nordisk
NVO
$228B
$430K 0.02%
16,842
+2,402
+17% +$59.4K
HPE icon
234
Hewlett Packard
HPE
$62.4B
$428K 0.02%
+28,606
New +$434K
RY icon
235
Royal Bank of Canada
RY
$292B
$425K 0.02%
5,358
+287
+6% +$22.4K
HAL icon
236
Halliburton
HAL
$26.4B
$423K 0.02%
+18,611
New +$483K
WY icon
237
Weyerhaeuser
WY
$16.9B
$422K 0.02%
+15,991
New +$406K
LRCX icon
238
Lam Research
LRCX
$372B
$419K 0.02%
22,310
+800
+4% +$15.2K
MTD icon
239
Mettler-Toledo International
MTD
$27.9B
$418K 0.02%
498
+19
+4% +$14.3K
PGR icon
240
Progressive
PGR
$124B
$412K 0.02%
5,153
+21
+0.4% +$1.62K
CVS icon
241
CVS Health
CVS
$134B
$409K 0.02%
7,511
+2,876
+62% +$155K
SRE icon
242
Sempra
SRE
$58.6B
$400K 0.02%
5,824
+900
+18% +$59K
VTR icon
243
Ventas
VTR
$44.7B
$400K 0.02%
+5,856
New +$373K
CLX icon
244
Clorox
CLX
$11.7B
$396K 0.02%
+2,594
New +$396K
LMT icon
245
Lockheed Martin
LMT
$132B
$395K 0.02%
1,087
+254
+30% +$85K
SYF icon
246
Synchrony
SYF
$25.1B
$390K 0.02%
+11,251
New +$381K
PRU icon
247
Prudential Financial
PRU
$42.6B
$384K 0.02%
3,801
+212
+6% +$21.1K
COP icon
248
ConocoPhillips
COP
$145B
$383K 0.02%
6,281
+897
+17% +$55.8K
WBK
249
DELISTED
Westpac Banking Corporation
WBK
$382K 0.02%
19,157
+4,605
+32% +$88.2K
CP icon
250
Canadian Pacific Kansas City
CP
$78.3B
$381K 0.02%
8,115
+1,300
+19% +$58.1K
8 9
10
11 12

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return

Ballentine Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Ballentine Partners held 408 positions worth $2.08B, up 8.4% from $1.92B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Ballentine Partners deployed $113M of net new capital in Q2 2019, opening 78 new positions and adding to 225 existing holdings. Its largest new stake was Trane Technologies: 19,794 shares worth $2.51M.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $3.46M trimmed.

  • Ballentine Partners's largest Q2 2019 buy was Trane Technologies: 19,794 shares worth $2.51M.
  • Ballentine Partners added most to Vanguard Morningstar Total Stock Market ETF in Q2 2019, an estimated $30.9M increase.
  • Ballentine Partners's biggest Q2 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $3.46M.
  • Ballentine Partners fully exited Goldcorp Inc in Q2 2019, selling an estimated $483K.
  • Ballentine Partners's ten largest holdings make up 60% of its $2.08B portfolio in Q2 2019.
  • Ballentine Partners opened 78 new positions and closed 9 in Q2 2019.
  • Ballentine Partners's portfolio value rose 8.4% quarter-over-quarter to $2.08B.

Based on Ballentine Partners's 13F filing for Q2 2019, filed 25 Jul 2019.